Table of Contents
Cardiovascular Psychiatry and Neurology
Volume 2009, Article ID 545263, 5 pages
http://dx.doi.org/10.1155/2009/545263
Hypothesis

P 2 X 7 Receptors as a Transducer in the Co-Occurrence of Neurological/Psychiatric and Cardiovascular Disorders: A Hypothesis

Department of Pharmacology and Anesthesiology, University of Padova, Largo “E.Meneghetti” 2, 35131 Padova, Italy

Received 23 May 2009; Accepted 19 June 2009

Academic Editor: Hari Manev

Copyright © 2009 Stephen D. Skaper and Pietro Giusti. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. D. Skaper, P. Debetto, and P. Giusti, “P2X7 receptors in neurological and cardiovascular disorders,” Cardiovascular Psychiatry and Neurology. In press.
  2. R. A. North, “Molecular physiology of P2X receptors,” Physiological Reviews, vol. 82, no. 4, pp. 1013–1067, 2002. View at Publisher · View at Google Scholar · View at PubMed
  3. A. Surprenant, F. Rassendren, E. Kawashima, R. A. North, and G. Buell, “The cytolytic P2Z receptor for extracellular ATP identified as a P2X receptor (P2X7 ),” Science, vol. 272, no. 5262, pp. 735–738, 1996. View at Publisher · View at Google Scholar
  4. P. Ballerini, R. Ciccarelli, F. Caciagli et al., “P2X7 receptor activation in rat brain cultured astrocytes increases the biosynthetic release of cysteinyl leukotrienes,” International Journal of Immunopathology and Pharmacology, vol. 18, no. 3, pp. 417–430, 2005. View at Google Scholar
  5. E. Porreca, P. Conti, C. Feliciani et al., “Cysteinyl-leukotriene D4 induced IL-1β expression and release in rat vascular smooth muscle cells,” Atherosclerosis, vol. 115, no. 2, pp. 181–189, 1995. View at Publisher · View at Google Scholar
  6. A. Filippini, R. E. Taffs, T. Agui, and M. V. Sitkovsky, “Ecto-ATPase activity in cytolytic T-lymphocytes. Protection from the cytolytic effects of extracellular ATP,” Journal of Biological Chemistry, vol. 265, no. 1, pp. 334–340, 1990. View at Google Scholar
  7. A. Sikora, J. Liu, C. Brosnan, G. Buell, I. Chessel, and B. R. Bloom, “Cutting edge: purinergic signaling regulates radical-mediated bacterial killing mechanisms in macrophages through a P2X7-independent mechanism,” Journal of Immunology, vol. 163, no. 2, pp. 558–561, 1999. View at Google Scholar
  8. D. Ferrari, P. Chiozzi, S. Falzoni et al., “ATP-mediated cytotoxicity in microglial cells,” Neuropharmacology, vol. 36, no. 9, pp. 1295–1301, 1997. View at Publisher · View at Google Scholar
  9. R. Beigi, E. Kobatake, M. Aizawa, and G. R. Dubyak, “Detection of local ATP release from activated platelets using cell surface-attached firefly luciferase,” American Journal of Physiology, vol. 276, no. 1 45-1, pp. C267–C278, 1999. View at Google Scholar
  10. G. R. Dubyak and C. el-Moatassim, “Signal transduction via P2-purinergic receptors for extracellular ATP and other nucleotides,” The American Journal of Physiology, vol. 265, no. 3, part 1, pp. C577–606, 1993. View at Google Scholar
  11. E. R. Lazarowski, R. C. Boucher, and T. K. Harden, “Constitutive release of ATP and evidence for major contribution of ecto-nucleotide pyrophosphatase and nucleoside diphosphokinase to extracellular nucleotide concentrations,” Journal of Biological Chemistry, vol. 275, no. 40, pp. 31061–31068, 2000. View at Publisher · View at Google Scholar · View at PubMed
  12. K. Nieber, D. Eschke, and A. Brand, “Brain hypoxia: effects of ATP and adenosine,” Progress in Brain Research, vol. 120, pp. 287–297, 1999. View at Publisher · View at Google Scholar
  13. B. D. Humphreys and G. R. Dubyak, “Modulation of P2X7 nucleotide receptor expression by pro- and anti-inflammatory stimuli in THP-1 monocytes,” Journal of Leukocyte Biology, vol. 64, no. 2, pp. 265–273, 1998. View at Google Scholar
  14. F. Di Virgilio, P. Chiozzi, D. Ferrari et al., “Nucleotide receptors: an emerging family of regulatory molecules in blood cells,” Blood, vol. 97, no. 3, pp. 587–600, 2001. View at Publisher · View at Google Scholar
  15. M. Solle, J. Labasi, D. G. Perregaux et al., “Altered cytokine production in mice lacking P2X7 receptors,” Journal of Biological Chemistry, vol. 276, no. 1, pp. 125–132, 2001. View at Publisher · View at Google Scholar · View at PubMed
  16. D. Ferrari, C. Pizzirani, E. Adinolfi et al., “The P2X7 receptor: a key player in IL-1 processing and release,” Journal of Immunology, vol. 176, no. 7, pp. 3877–3883, 2006. View at Google Scholar
  17. R. Le Feuvre, D. Brough, and N. Rothwell, “Extracellular ATP and P2X7 receptors in neurodegeneration,” European Journal of Pharmacology, vol. 447, no. 2-3, pp. 261–269, 2002. View at Publisher · View at Google Scholar
  18. I. P. Chessell, J. P. Hatcher, C. Bountra et al., “Disruption of the P2X7 purinoceptor gene abolishes chronic inflammatory and neuropathic pain,” Pain, vol. 114, no. 3, pp. 386–396, 2005. View at Publisher · View at Google Scholar · View at PubMed
  19. R. W. Keane, A. R. Davis, and W. D. Dietrich, “Inflammatory and apoptotic signaling after spinal cord injury,” Journal of Neurotrauma, vol. 23, no. 3-4, pp. 335–344, 2006. View at Publisher · View at Google Scholar · View at PubMed
  20. X. Wang, G. Arcuino, T. Takano et al., “P2X7 receptor inhibition improves recovery after spinal cord injury,” Nature Medicine, vol. 10, no. 8, pp. 821–827, 2004. View at Publisher · View at Google Scholar · View at PubMed
  21. L. K. Parvathenani, S. Tertyshnikova, C. R. Greco, S. B. Roberts, B. Robertson, and R. Posmantur, “P2X7 mediates superoxide production in primary microglia and is up-regulated in a transgenic mouse model of Alzheimer's disease,” Journal of Biological Chemistry, vol. 278, no. 15, pp. 13309–13317, 2003. View at Publisher · View at Google Scholar · View at PubMed
  22. H. Franke, A. Günther, J. Grosche et al., “P2X7 receptor expression after ischemia in the cerebral cortex of rats,” Journal of Neuropathology and Experimental Neurology, vol. 63, no. 7, pp. 686–699, 2004. View at Google Scholar
  23. L. Narcisse, E. Scemes, Y. Zhao, S. C. Lee, and C. F. Brosnan, “The cytokine IL-1β transiently enhances P2X7 receptor expression and function in human astrocytes,” GLIA, vol. 49, no. 2, pp. 245–258, 2005. View at Publisher · View at Google Scholar · View at PubMed
  24. S. D. Skaper, L. Facci, A. A. Culbert et al., “P2X7 receptors on microglial cells mediate injury to cortical neurons in vitro,” GLIA, vol. 54, no. 3, pp. 234–242, 2006. View at Publisher · View at Google Scholar · View at PubMed
  25. J. M. Labasi, N. Petrushova, C. Donovan et al., “Absence of the P2X7 receptor alters leukocyte function and attenuates an inflammatory response,” Journal of Immunology, vol. 168, no. 12, pp. 6436–6445, 2002. View at Google Scholar
  26. O. Touzani, H. Boutin, J. Chuquet, and N. Rothwell, “Potential mechanisms of interleukin-1 involvement in cerebral ischaemia,” Journal of Neuroimmunology, vol. 100, no. 1-2, pp. 203–215, 1999. View at Publisher · View at Google Scholar
  27. H. Anisman and Z. Merali, “Cytokines, stress, and depressive illness,” Brain, Behavior, and Immunity, vol. 16, no. 5, pp. 513–524, 2002. View at Publisher · View at Google Scholar
  28. R. S. Smith, “The macrophage theory of depression,” Medical Hypotheses, vol. 35, no. 4, pp. 298–306, 1991. View at Publisher · View at Google Scholar
  29. H. Anisman, Z. Merali, M. O. Poulter, and S. Hayley, “Cytokines as a precipitant of depressive illness: animal and human studies,” Current Pharmaceutical Design, vol. 11, no. 8, pp. 963–972, 2005. View at Publisher · View at Google Scholar
  30. M. R. Kraus, A. Schäfer, H. Faller, H. Csef, and M. Scheurlen, “Paroxetine for the treatment of interferon-α-induced depression in chronic hepatitis C,” Alimentary Pharmacology and Therapeutics, vol. 16, no. 6, pp. 1091–1099, 2002. View at Publisher · View at Google Scholar
  31. J. Steiner, H. Bielau, R. Brisch et al., “Immunological aspects in the neurobiology of suicide: elevated microglial density in schizophrenia and depression is associated with suicide,” Journal of Psychiatric Research, vol. 42, no. 2, pp. 151–157, 2008. View at Publisher · View at Google Scholar · View at PubMed
  32. M. Maes, “Major depression and activation of the inflammatory response system,” Advances in Experimental Medicine and Biology, vol. 461, pp. 25–46, 1999. View at Publisher · View at Google Scholar
  33. C. Tuglu, S. H. Kara, O. Caliyurt, E. Vardar, and E. Abay, “Increased serum tumor necrosis factor-alpha levels and treatment response in major depressive disorder,” Psychopharmacology, vol. 170, no. 4, pp. 429–433, 2003. View at Publisher · View at Google Scholar · View at PubMed
  34. S. Alesci, P. E. Martinez, S. Kelkar et al., “Major depression is associated with significant diurnal elevations in plasma interleukin-6 levels, a shift of its circadian rhythm, and loss of physiological complexity in its secretion: clinical implications,” Journal of Clinical Endocrinology and Metabolism, vol. 90, no. 5, pp. 2522–2530, 2005. View at Publisher · View at Google Scholar · View at PubMed
  35. Z. Mallat and A. Tedgui, “Apoptosis in the vasculature: mechanisms and functional importance,” British Journal of Pharmacology, vol. 130, no. 5, pp. 947–962, 2000. View at Publisher · View at Google Scholar · View at PubMed
  36. G. Burnstock, “Release of vasoactive substances from endothelial cells by shear stress and purinergic mechanosensory transduction,” Journal of Anatomy, vol. 194, no. 3, pp. 335–342, 1999. View at Publisher · View at Google Scholar
  37. A. K. Dutta, R. Z. Sabirov, H. Uramoto, and Y. Okada, “Role of ATP-conductive anion channel in ATP release from neonatal rat cardiomyocytes in ischaemic or hypoxic conditions,” Journal of Physiology, vol. 559, no. 3, pp. 799–812, 2004. View at Publisher · View at Google Scholar · View at PubMed
  38. G. H. Gibbons, “Autocrine-paracrine factors and vascular remodeling in hypertension,” Current Opinion in Nephrology and Hypertension, vol. 2, no. 2, pp. 291–298, 1993. View at Publisher · View at Google Scholar
  39. Y. Zhang, D. Sanchez, J. Gorelik et al., “Basolateral P2X4-like receptors regulate the extracellular ATP-stimulated epithelial Na+ channel activity in renal epithelia,” American Journal of Physiology, vol. 292, no. 6, pp. F1734–F1740, 2007. View at Publisher · View at Google Scholar · View at PubMed
  40. J. Palomino-Doza, T. J. Rahman, P. J. Avery et al., “Ambulatory blood pressure is associated with polymorphic variation in P2X receptor genes,” Hypertension, vol. 52, no. 5, pp. 980–985, 2008. View at Publisher · View at Google Scholar · View at PubMed
  41. C. Cario-Toumaniantz, G. Loirand, A. Ladoux, and P. Pacaud, “P2X7 receptor activation-induced contraction and lysis in human saphenous vein smooth muscle,” Circulation Research, vol. 83, no. 2, pp. 196–203, 1998. View at Google Scholar
  42. E. Duner, F. Di Virgilio, R. Trevisan, M. R. Cipollina, G. Crepaldi, and R. Nosadini, “Intracellular free calcium abnormalities in fibroblasts from non-insulin-dependent diabetic patients with and without arterial hypertension,” Hypertension, vol. 29, no. 4, pp. 1007–1013, 1997. View at Google Scholar
  43. A. Solini, P. Chiozzi, A. Morelli et al., “Enhanced P2X7 activity in human fibroblasts from diabetic patients: a possible pathogenetic mechanism for vascular damage in diabetes,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 24, no. 7, pp. 1240–1245, 2004. View at Publisher · View at Google Scholar · View at PubMed
  44. M. Maes, “Evidence for an immune response in major depression: a review and hypothesis,” Progress in Neuro-Psychopharmacology and Biological Psychiatry, vol. 19, no. 1, pp. 11–38, 1995. View at Publisher · View at Google Scholar
  45. A. H. Glassman, “Depression and cardiovascular comorbidity,” Dialogues in Clinical Neuroscience, vol. 9, no. 1, pp. 9–17, 2007. View at Google Scholar
  46. J. C. Stewart, K. L. Rand, M. F. Muldoon, and T. W. Kamarck, “A prospective evaluation of the directionality of the depression-inflammation relationship,” Brain, Behavior, and Immunity. In press. View at Publisher · View at Google Scholar · View at PubMed